AFP values were available for 185/225 patients (82.2%), including 120/132 (90.9%) HCC mFLLs, 16/22 (72.7%) non-HCC mFLLs, and 49/71 (69.0%) bFLLs. The gene discussed is AFP; the disease is hepatocellular carcinoma.